Cranial neural tube defect after trimethoprim exposure
Objectives: The Neural Tube Defects Research Group of University of Malaya was approached to analyze a tablet named TELSE, which may have resulted in a baby born with central nervous system malformation at the University of Malaya Medical Centre. In this animal experimental study, we investigated th...
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Published: |
BMC
2018
|
| Subjects: |
| _version_ | 1825721929208692736 |
|---|---|
| author | Abdullah, Nor Linda Gunasekaran, Renuka Mohd-Zin, Siti Waheeda Lim, Bee Hui Maniam, Pramila Mohd-Salleh, Anis Shuhada Thong, Meow Keong Chik, Zamri Nordin, Noreena Omar, Zaliha Engkasan, Julia Patrick Ganesan, Dharmendra Aiezzah, Zakaria Nurul Ahmad-Annuar, Azlina Abdul-Aziz, Noraishah Mydin |
| author_facet | Abdullah, Nor Linda Gunasekaran, Renuka Mohd-Zin, Siti Waheeda Lim, Bee Hui Maniam, Pramila Mohd-Salleh, Anis Shuhada Thong, Meow Keong Chik, Zamri Nordin, Noreena Omar, Zaliha Engkasan, Julia Patrick Ganesan, Dharmendra Aiezzah, Zakaria Nurul Ahmad-Annuar, Azlina Abdul-Aziz, Noraishah Mydin |
| author_sort | Abdullah, Nor Linda |
| collection | UM |
| description | Objectives: The Neural Tube Defects Research Group of University of Malaya was approached to analyze a tablet named TELSE, which may have resulted in a baby born with central nervous system malformation at the University of Malaya Medical Centre. In this animal experimental study, we investigated the content of TELSE and exposure of its contents that resulted in failure of primary neurulation. Results: Liquid Chromatography Tandem Mass spectrophotometry analysis of the TELSE tablet confirmed the presence of trimethoprim as the active compound. The TELSE tablet-treated females produced significant numbers of embryos with exencephaly (n = 8, 36.4%,∗P < 0.0001), in all litters. The TELSE tablet-treated females subsequently given folic acid did not result in pregnancies despite there being evidence of possible resorption. Furthermore, after multiple rounds of mating which did not yield viable pregnancies, eventually, 2 embryos with exencephaly were harvested in a litter of 6 at 0.05% w/v pure trimethoprim once. The use of trimethoprim, a folic acid antagonist, peri-conceptionally increased the risk of exencephaly in the mouse. |
| first_indexed | 2024-03-06T05:57:51Z |
| format | Article |
| id | um.eprints-22736 |
| institution | Universiti Malaya |
| last_indexed | 2024-03-06T05:57:51Z |
| publishDate | 2018 |
| publisher | BMC |
| record_format | dspace |
| spelling | um.eprints-227362019-10-14T04:07:28Z http://eprints.um.edu.my/22736/ Cranial neural tube defect after trimethoprim exposure Abdullah, Nor Linda Gunasekaran, Renuka Mohd-Zin, Siti Waheeda Lim, Bee Hui Maniam, Pramila Mohd-Salleh, Anis Shuhada Thong, Meow Keong Chik, Zamri Nordin, Noreena Omar, Zaliha Engkasan, Julia Patrick Ganesan, Dharmendra Aiezzah, Zakaria Nurul Ahmad-Annuar, Azlina Abdul-Aziz, Noraishah Mydin R Medicine Objectives: The Neural Tube Defects Research Group of University of Malaya was approached to analyze a tablet named TELSE, which may have resulted in a baby born with central nervous system malformation at the University of Malaya Medical Centre. In this animal experimental study, we investigated the content of TELSE and exposure of its contents that resulted in failure of primary neurulation. Results: Liquid Chromatography Tandem Mass spectrophotometry analysis of the TELSE tablet confirmed the presence of trimethoprim as the active compound. The TELSE tablet-treated females produced significant numbers of embryos with exencephaly (n = 8, 36.4%,∗P < 0.0001), in all litters. The TELSE tablet-treated females subsequently given folic acid did not result in pregnancies despite there being evidence of possible resorption. Furthermore, after multiple rounds of mating which did not yield viable pregnancies, eventually, 2 embryos with exencephaly were harvested in a litter of 6 at 0.05% w/v pure trimethoprim once. The use of trimethoprim, a folic acid antagonist, peri-conceptionally increased the risk of exencephaly in the mouse. BMC 2018 Article PeerReviewed Abdullah, Nor Linda and Gunasekaran, Renuka and Mohd-Zin, Siti Waheeda and Lim, Bee Hui and Maniam, Pramila and Mohd-Salleh, Anis Shuhada and Thong, Meow Keong and Chik, Zamri and Nordin, Noreena and Omar, Zaliha and Engkasan, Julia Patrick and Ganesan, Dharmendra and Aiezzah, Zakaria Nurul and Ahmad-Annuar, Azlina and Abdul-Aziz, Noraishah Mydin (2018) Cranial neural tube defect after trimethoprim exposure. BMC Research Notes, 11 (1). p. 475. ISSN 1756-0500, DOI https://doi.org/10.1186/s13104-018-3593-1 <https://doi.org/10.1186/s13104-018-3593-1>. https://doi.org/10.1186/s13104-018-3593-1 doi:10.1186/s13104-018-3593-1 |
| spellingShingle | R Medicine Abdullah, Nor Linda Gunasekaran, Renuka Mohd-Zin, Siti Waheeda Lim, Bee Hui Maniam, Pramila Mohd-Salleh, Anis Shuhada Thong, Meow Keong Chik, Zamri Nordin, Noreena Omar, Zaliha Engkasan, Julia Patrick Ganesan, Dharmendra Aiezzah, Zakaria Nurul Ahmad-Annuar, Azlina Abdul-Aziz, Noraishah Mydin Cranial neural tube defect after trimethoprim exposure |
| title | Cranial neural tube defect after trimethoprim exposure |
| title_full | Cranial neural tube defect after trimethoprim exposure |
| title_fullStr | Cranial neural tube defect after trimethoprim exposure |
| title_full_unstemmed | Cranial neural tube defect after trimethoprim exposure |
| title_short | Cranial neural tube defect after trimethoprim exposure |
| title_sort | cranial neural tube defect after trimethoprim exposure |
| topic | R Medicine |
| work_keys_str_mv | AT abdullahnorlinda cranialneuraltubedefectaftertrimethoprimexposure AT gunasekaranrenuka cranialneuraltubedefectaftertrimethoprimexposure AT mohdzinsitiwaheeda cranialneuraltubedefectaftertrimethoprimexposure AT limbeehui cranialneuraltubedefectaftertrimethoprimexposure AT maniampramila cranialneuraltubedefectaftertrimethoprimexposure AT mohdsallehanisshuhada cranialneuraltubedefectaftertrimethoprimexposure AT thongmeowkeong cranialneuraltubedefectaftertrimethoprimexposure AT chikzamri cranialneuraltubedefectaftertrimethoprimexposure AT nordinnoreena cranialneuraltubedefectaftertrimethoprimexposure AT omarzaliha cranialneuraltubedefectaftertrimethoprimexposure AT engkasanjuliapatrick cranialneuraltubedefectaftertrimethoprimexposure AT ganesandharmendra cranialneuraltubedefectaftertrimethoprimexposure AT aiezzahzakarianurul cranialneuraltubedefectaftertrimethoprimexposure AT ahmadannuarazlina cranialneuraltubedefectaftertrimethoprimexposure AT abdulaziznoraishahmydin cranialneuraltubedefectaftertrimethoprimexposure |